Biblio

Export 3139 results:
Author Title Type [ Year(Desc)]
2016
J. Min Song, Sung, Y. Me, Nam, J. Han, Yoon, H., Chung, A., Moffat, E., Jung, M., Pak, D. T. S., Kim, J., and Hoe, H. - S., “A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway.”, J Alzheimers Dis, vol. 51, no. 2, pp. 591-604, 2016.
K. Steenland, Goldstein, F. C., Levey, A., and Wharton, W., “A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians.”, J Alzheimers Dis, vol. 50, no. 1, pp. 71-6, 2016.
W. Wruck, Schröter, F., and Adjaye, J., “Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1065-82, 2016.
Q. Yao, Jiang, G. - X., Zhou, Z. - M., Chen, J. - M., and Cheng, Q., “Metabolic Syndrome and Mild Cognitive Impairment: A Case-Control Study among Elderly in a Shanghai Suburb.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1175-82, 2016.
P. Adam, Křížková, S., Heger, Z., Babula, P., Pekařík, V., Vaculovičoá, M., Gomes, C. M., Kizek, R., and Adam, V., “Metallothioneins in Prion- and Amyloid-Related Diseases.”, J Alzheimers Dis, vol. 51, no. 3, pp. 637-56, 2016.
S. Min Son, Shin, H. - J., Byun, J., Kook, S. Young, Moon, M., Chang, Y. Jin, and Mook-Jung, I., “Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1197-208, 2016.
J. A. Luchsinger, Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., and Bagiella, E., “Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.”, J Alzheimers Dis, vol. 51, no. 2, pp. 501-14, 2016.
J. Schuster and Funke, S. Aileen, “Methods for the Specific Detection and Quantitation of Amyloid-β Oligomers in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 53, no. 1, pp. 53-67, 2016.
A. Di Meco and Praticò, D., “MicroRNAs as Therapeutic Targets for Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 2, pp. 367-72, 2016.
P. Iso-Markku, Waller, K., Vuoksimaa, E., Heikkilä, K., Rinne, J., Kaprio, J., and Kujala, U. M., “Midlife Physical Activity and Cognition Later in Life: A Prospective Twin Study.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1303-1317, 2016.
D. S Han, Boyle, P. A., James, B. D., Yu, L., and Bennett, D. A., “Mild Cognitive Impairment and Susceptibility to Scams in Old Age.”, J Alzheimers Dis, vol. 49, no. 3, pp. 845-51, 2016.
D. J. Quintana-Hernández, Miró-Barrachina, M. T., Ibáñez-Fernández, I. J., Del Pino, A. Santana-, Quintana-Montesdeoca, M. P., de Vera, B. Rodríguez, Morales-Casanova, D., Pérez-Vieitez, M. Del Carmen, Rodríguez-García, J., and Bravo-Caraduje, N., “Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.”, J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
C. M. Smart, Segalowitz, S. J., Mulligan, B. P., Koudys, J., and Gawryluk, J. R., “Mindfulness Training for Older Adults with Subjective Cognitive Decline: Results from a Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 52, no. 2, pp. 757-74, 2016.
H. Li, Jia, J., and Yang, Z., “Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 487-96, 2016.
H. - H. Li, Lin, S. - L., Huang, C. - N., Lu, F. - J., Chiu, P. - Y., Huang, W. - N., Lai, T. - J., and Lin, C. - L., “miR-302 Attenuates Amyloid-β-Induced Neurotoxicity through Activation of Akt Signaling.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1083-98, 2016.
E. Idrizbegovic, Hederstierna, C., and Rosenhall, U., “Mismatch Negativity and Ear Laterality in Alzheimer's Disease and in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1405-10, 2016.
E. C. Edmonds, Delano-Wood, L., Jak, A. J., Galasko, D. R., Salmon, D. P., and Bondi, M. W., “"Missed" Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria.”, J Alzheimers Dis, vol. 52, no. 2, pp. 685-91, 2016.
R. C. Adiele and Adiele, C. A., “Mitochondrial Regulatory Pathways in the Pathogenesis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1257-70, 2016.
C. Stockburger, Miano, D., Baeumlisberger, M., Pallas, T., Arrey, T. N., Karas, M., Friedland, K., and Müller, W. E., “A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.”, J Alzheimers Dis, vol. 50, no. 1, pp. 201-15, 2016.
K. Hoffmann, Sobol, N. A., Frederiksen, K. S., Beyer, N., Vogel, A., Vestergaard, K., Brændgaard, H., Gottrup, H., Lolk, A., Wermuth, L., Jacobsen, S., Laugesen, L. P., Gergelyffy, R. G., Høgh, P., Bjerregaard, E., Andersen, B. B., Siersma, V., Johannsen, P., Cotman, C. W., Waldemar, G., and Hasselbalch, S. G., “Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 50, no. 2, pp. 443-53, 2016.
C. Merino-Zamorano, de Retana, S. Fernández, Montañola, A., Batlle, A., Saint-Pol, J., Mysiorek, C., Gosselet, F., Montaner, J., and Hernández-Guillamon, M., “Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 53, no. 2, pp. 677-91, 2016.
M. Zhu, Huang, C., Ma, X., Wu, R., Zhu, W., Li, X., Liang, Z., Deng, F., Zhu, J., Xie, W., Yang, X., Jiang, Y., Wang, S., Wu, J., Geng, S., Xie, C., and Zhong, C., “Modulation of miR-19 in Aluminum-Induced Neural Cell Apoptosis.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1149-62, 2016.
M. Edwards, Hall, J., Williams, B., Johnson, L., and O'Bryant, S., “Molecular markers of amnestic mild cognitive impairment among Mexican Americans.”, J Alzheimers Dis, vol. 49, no. 1, pp. 221-8, 2016.
M. Chakrabarti, McDonald, A. J., J Reed, W., Moss, M. A., Das, B. C., and Ray, S. K., “Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 335-52, 2016.
I. Blockx, Einstein, S., Guns, P. - J., Van Audekerke, J., Guglielmetti, C., Zago, W., Roose, D., Verhoye, M., Van der Linden, A., and Bard, F., “Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model.”, J Alzheimers Dis, vol. 54, no. 2, pp. 723-35, 2016.

Pages